Walleye Capital
GMED icon

Walleye Capital’s Globus Medical GMED Stock Holding History

Walleye Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
2,800
+300
+12% +$25.5K ﹤0.01% 3424
2026
Q1 		$215K Sell
2,500
-1,200
-32% -$108K ﹤0.01% 3299
2025
Q4 		$323K Buy
+3,700
New +$281K ﹤0.01% 3252
2025
Q3 		– Sell
-100
Closed -$5.9K – 4729
2025
Q2 		$5.9K Buy
+100
New +$6.46K ﹤0.01% 4350
2024
Q4 		– Sell
-1,200
Closed -$85.8K – 5098
2024
Q3 		$85.8K Sell
1,200
-4,800
-80% -$339K ﹤0.01% 4455
2024
Q2 		$411K Buy
6,000
+4,800
+400% +$287K ﹤0.01% 3674
2024
Q1 		$64.4K Sell
1,200
-1,000
-45% -$53.8K ﹤0.01% 4587
2023
Q4 		$117K Buy
+2,200
New +$107K ﹤0.01% 3979

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Walleye Capital's GMED Position: Q2 2026 in Review

Walleye Capital increased its Globus Medical (GMED) stake by 579,237% in Q2 2026, buying an estimated $13.3M and bringing the position to 156,421 shares worth $12.4M. The position accounts for 0.04% of the portfolio, ranked #395.

Walleye Capital first reported a position in GMED in Q4 2020 and has held it in 23 quarters since. The position peaked at $71.5M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Walleye Capital held 156,421 shares of Globus Medical worth $12.4M as of Q2 2026.
  • Walleye Capital bought 156,394 Globus Medical shares in Q2 2026, an estimated $13.3M.
  • Globus Medical made up 0.04% of Walleye Capital's portfolio in Q2 2026, its #395 holding.
  • Walleye Capital first reported a position in Globus Medical in Q4 2020 and has held it in 23 quarters since.
  • Walleye Capital's Globus Medical position peaked at $71.5M in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.